Suraksha Diagnostic IPO Details
| IPO Open Date: | November 29, 2024 |
| IPO Close Date: | December 3, 2024 |
| Face Value: | ₹2 Per Equity Share |
| IPO Price Band: | ₹420 to ₹441 Per Share |
| Issue Size: | Approx ₹846.25 Crores |
| Offer for Sale: | Approx 1,91,89,330 Equity Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Suraksha Diagnostic IPO Market Lot
The Suraksha Diagnostic IPO minimum market lot is 34 shares with ₹14,994 application amount. The retail investors can apply up-to 13 lots with 442 shares or ₹1,94,922 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 34 | ₹14,994 |
| Retail Maximum | 13 | 442 | ₹1,94,922 |
| S-HNI Minimum | 14 | 476 | ₹2,09,916 |
| S-HNI Maximum | 66 | 2,244 | ₹9,89,604 |
| B-HNI Minimum | 67 | 2,278 | ₹1,004,598 |
Suraksha Diagnostic IPO Dates
The Suraksha Diagnostic IPO date is November 29, 2024 and the close date is December 3, 2024. The Suraksha Diagnostic IPO allotment will be finalized on December 4, 2024 and the IPO listing on December 6, 2024.
| IPO Open Date: | November 29, 2024 |
| IPO Close Date: | December 3, 2024 |
| Basis of Allotment: | December 4, 2024 |
| Refunds: | December 5, 2024 |
| Credit to Demat Account: | December 5, 2024 |
| IPO Listing Date: | December 6, 2024 |
Promoters of Suraksha Diagnostic IPO
The promoters of the company are Dr. Somnath Chatterjee, Ms. Ritu Mittal, and Mr. Satish Kumar Verma.
About Suraksha Diagnostic IPO
Suraksha Diagnostic was incorporated on 15 March 2005 and offers services like Medical testing, diagnostic solutions, and medical consultation. It is headquartered in East India and caters end-to-end solutions of pathology and radiology testing to its consumers through its functional network. Over time, it has collected various awards for identifying the brand’s awareness and focus in business. It has a good portfolio of over 2,300 tests including 788 pathology tests like basic biochemistry and haematology. 647 tests including advanced biochemistry, histopathology, and molecular pathology. In FY 2022 and 2024, the compounded annual growth rate(CAGR) of 20.87% in revenue and net income for FY 2024 was 23.13 crore. Furthermore, The leading diagnostic network with a strong presence in eastern India, outstanding profitability, and consistency in financial performance is a strength of this company. Due to its expertise have 1,522 permanent staff in the company.
Suraksha Diagnostic IPO Company Financial Report
The company reported revenue of ₹218.71 crores in 2024 against ₹190.13 crore in 2023. The company reported Profit of ₹23.13 crores in 2024 against Profit of ₹6.07 crores in 2023.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹223.19 | ₹197.76 | ₹20.82 | ₹275.96 |
| 2023 | ₹190.13 | ₹186.94 | ₹6.07 | ₹281.20 |
| 2024 | ₹218.71 | ₹190.03 | ₹23.13 | ₹300.21 |
Suraksha Diagnostic IPO Valuation – FY2024
Check Suraksha Diagnostic IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 14.09% |
| ROCE: | 21.46% |
| EBITDA Margin: | 33.66% |
| PAT Margin: | 10.57% |
| Debt to equity ratio: | 0.20 |
| Earning Per Share (EPS): | ₹4.43 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 14.09% |
| Net Asset Value (NAV): | ₹33.66 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Dr Lal PathLabs | 43.05 | 68.66 | 20.35 | 221.47 | 2226.60 Cr. |
| Metropolis Healthcare | 24.95 | 82.57 | 12.26 | 213.98 | 1207.71 Cr. |
| Thyrocare | 13.42 | 47.60 | 13.34 | 99.48 | 571.88 Cr. |
| Vijaya Diagnostic | 11.62 | 67.65 | 19.77 | 64.21 | 547.81 Cr. |
Objects of the Issue
- To carry out the Offer for Sale of up to 19,189,330 Equity Shares of face value ₹ 2 each aggregating to ₹ [●] million by the Selling Shareholders; and
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges.
Suraksha Diagnostic IPO Review
- IPO Watch – May Apply
- Canara Bank –
- DRChoksey FinServ –
- Emkay Global –
- Hem Securities –
- IDBI Capital –
- Marwadi Shares –
- Nirmal Bang –
- SBICAP Securities –
- Sharekhan –
- SMC Global –
- Sushil Finance –
- Swastika Investmart – Avoid
- Ventura Securities –
- Geojit –
- Reliance Securities –
- Capital Market – Avoid
- BP Wealth –
- ICICIdirect –
- Choice Broking –
Suraksha Diagnostic IPO Registrar
KFin Technologies Limited
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Phone: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com
IPO Lead Managers aka Merchant Bankers
- Nuvama Wealth and Investment Limited
Company Address
Suraksha Diagnostic Limited
Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327,
New Town, Rajarhat, Kolkata 700 156, West Bengal, India
Phone: +91 33 66059750
Email: [email protected]
Website: www.surakshanet.com
Suraksha Diagnostic IPO FAQs
What is Suraksha Diagnostic IPO?
When Suraksha Diagnostic IPO will open for subscription?
What is Suraksha Diagnostic IPO Investors Portion?
How to Apply the Suraksha Diagnostic IPO?
What is Suraksha Diagnostic IPO Issue Size?
What is Suraksha Diagnostic IPO Price Band?
What is Suraksha Diagnostic IPO Lot Size?
What is the Suraksha Diagnostic IPO Allotment Date?
What is the Suraksha Diagnostic IPO Listing Date?
Note: The Suraksha Diagnostic IPO price band and date are officially announced. The (Suraksha Diagnostic IPO grey market premium) will be added to the IPO GMP page as it will start).
